Frequency of natural regulatory T cells specific for factor VIII in the peripheral blood of healthy donors

Archive ouverte

Menier, Catherine | Meunier, Sylvain | Porcheddu, Valeria | Romano, Laurène | Correia, Evelyne | Busato, Florence | Tost, Jorg | Maillère, Bernard

Edité par CCSD ; Wiley-VCH Verlag -

International audience. Tolerance to self‐proteins involves multiple mechanisms, including conventional CD4 + T‐cell (Tconv) deletion in the thymus and the recruitment of natural regulatory T cells (nTregs). The significant incidence of autoantibodies specific for the blood coagulation factor VIII (FVIII) in healthy donors illustrates that tolerance to self‐proteins is not always complete. In contrast to FVIII‐specific Tconvs, FVIII‐specific nTregs have never been revealed and characterized. To determine the frequency of FVIII‐specific Tregs in human peripheral blood, we assessed the specificity of in vitro expanded Tregs by the membrane expression of the CD137 activation marker. Amplified Tregs maintain high levels of FOXP3 expression and exhibit almost complete demethylation of the FOXP3 Treg‐specific demethylated region. The cells retained FOXP3 expression after long‐term culture in vitro, strongly suggesting that FVIII‐specific Tregs are derived from the thymus. From eleven healthy donors, we estimated the frequencies of FVIII‐specific Tregs at 0.17 cells per million, which is about 10‐fold lower than the frequency of FVIII‐specific CD4 + T cells we previously published. Our results shed light on the mechanisms of FVIII tolerance by a renewed approach that could be extended to other self‐ or non‐self‐antigens.

Suggestions

Du même auteur

Specificity of the T Cell Response to Protein Biopharmaceuticals

Archive ouverte | Meunier, Sylvain | CCSD

International audience. The anti-drug antibody (ADA) response is an undesired humoral response raised against protein biopharmaceuticals (BPs) which can dramatically disturb their therapeutic properties. One particu...

Pegylation Reduces the Uptake of Certolizumab Pegol by Dendritic Cells and Epitope Presentation to T-Cells

Archive ouverte | de Bourayne, Marie | CCSD

International audience. Pegylation of biopharmaceuticals is the most common strategy to increase their half-life in the blood and is associated with a reduced immunogenicity. As antigen presentation is a primary eve...

Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab

Archive ouverte | Spindeldreher, Sebastian | CCSD

International audience

Chargement des enrichissements...